NCT00605943View on ClinicalTrials.gov

Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2008

Primary Completion Date

August 4, 2009

Study Completion Date

August 4, 2009

Conditions
Macular Degeneration
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00605943 - Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab | Biotech Hunter | Biotech Hunter